CLINICAL_TRIALS
trial_result
· 2024-04-15
Clinical Trial Update: Clinical Trial of Efficacy and Safety of Levopront® 30 mg/5 ml in Patients With Dry Cough [Phase 3]
Summary
Phase 3 trial evaluating the efficacy and safety of Levopront 30 mg/5 ml for dry cough has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dompé Farmaceutici S.p.A | Conditions: Cough | Phase 3 | Status: COMPLETED | Results posted: 2024-04-15